Sign In
Buy HRMY
$32.10
+1.19 (+3.85%)
At Close: Jun 03, 2026
Harmony Biosciences, The No. 3 Biotech, Just Topped Forecasts; But Concerns Persist
09:51am, Tuesday, 21'st Feb 2023
Harmony Biosciences beat quarterly expectations Tuesday, leading the biotech stock to surge despite a barrage of commercial concerns. The post Harmony Biosciences, The No.
The 7 Best Biotech Stocks to Buy for February 2023
01:51pm, Tuesday, 07'th Feb 2023
While unpredictable compared to other sectors due to the ebb and flow of clinical trials, the best biotech stocks to buy offer investors incredible upside opportunities. Better yet, the volatility lar
HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS ON FEBRUARY 21, 2023
08:05am, Tuesday, 07'th Feb 2023
PLYMOUTH MEETING, Pa. , Feb. 7, 2023 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (NASDAQ: HRMY), a pharmaceutical company dedicated to developing and commercializin
2 Biotechs Making Waves With A Single Product in their Pipeline
10:10am, Thursday, 12'th Jan 2023
Catalyst Pharmaceuticals and Harmony Bioscience each have a single product in their respective pipelines, and both show incredible promise.
Strength Seen in Harmony Biosciences Holdings, Inc. (HRMY): Can Its 5.1% Jump Turn into More Strength?
09:02am, Wednesday, 11'th Jan 2023
Harmony Biosciences Holdings, Inc. (HRMY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest fu
IPO Stock Leaders Harmony, ProFrac Outperform Despite Tough 2022 Market
12:52pm, Friday, 30'th Dec 2022
Despite a struggling IPO market in 2022, Harmony Biosciences and ProFrac are holding up well in the ongoing stock market correction. The post IPO Stock Leaders Harmony, ProFrac Outperform Despite Toug
HARMONY BIOSCIENCES TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
08:05am, Thursday, 22'nd Dec 2022
PLYMOUTH MEETING, Pa. , Dec. 22, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializi
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
12:24pm, Wednesday, 14'th Dec 2022
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
Harmony Biosciences: Up 40% Since My Last Coverage, Waiting For Another Opportunity
03:42am, Wednesday, 14'th Dec 2022
Harmony has done very well in the few months since I last covered it. I was overly cautious then and did not buy what I see could have been a great investment.
Hot Biotech Stocks Rise Into Leadership; Pass Buy Points Or Build Bases
02:10pm, Friday, 25'th Nov 2022
Top biotech stocks surge within the IBD 50. Some pass buy points while others build bases.
Why Harmony Biosciences (HRMY) Stock Might be a Great Pick
10:32am, Wednesday, 23'rd Nov 2022
Harmony Biosciences (HRMY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Harmony Biosciences Holdings, Inc. (HRMY) Q3 2022 Earnings Call Transcript
03:15pm, Tuesday, 01'st Nov 2022
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY ) Q3 2022 Earnings Conference Call November 1, 2022 8:30 AM ET Company Participants Luis Sanay - Head-Investor Relations John Jacobs - President & Chief
Harmony Biosciences Holdings, Inc. (HRMY) Beats Q3 Earnings and Revenue Estimates
10:32am, Tuesday, 01'st Nov 2022
Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 850% and 3.62%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead f
IPO Stock Of The Week: Harmony Biosciences Outperforms In A Tough Market
01:01pm, Friday, 21'st Oct 2022
IPO Stock Of The Week Harmony Biosciences is holding up well during the stock market correction. The post IPO Stock Of The Week: Harmony Biosciences Outperforms In A Tough Market appeared first on Inv
HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2022 FINANCIAL RESULTS ON NOVEMBER 1, 2022
08:05am, Tuesday, 18'th Oct 2022
PLYMOUTH MEETING, Pa. , Oct. 18, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (NASDAQ: HRMY), a pharmaceutical company dedicated to developing and commercializi
